Multiple Sclerosis (MS) is considered as the most common disease of the central nervous system, causing permanent disabilities in adults (
1). Multiple Sclerosis is also regarded as a degenerative disease of the central nervous system that is chronic and progressive and characterized by destruction of myelin sheath in the brain and the spinal cord (
2). In addition, MS is known as the second most common cause of disabilities in young adults after traffic accidents (
3). The first demonstrations of MS usually arise at 20 to 40 years of age with symptoms, such as depression, anxiety, weakness, impaired vision, as well as imbalance (
4). The cause of MS is unknown although there are theories about the impact of immunological, genetic, and environmental factors, as well as viruses (
5). According to available statistics, about 2.5 million people around the world and 40 thousand individuals in Iran have this disease (
6,
7).
Multiple Sclerosis often has a period of relapsing and remitting; during remission, there are usually no symptoms and emergence of symptoms are known as attacks (
8). In this disease, damage to the myelin sheath can lead to cognitive disorders, spasms, depression, pain, and fatigue (
9). Moreover, MS as a chronic disease with no permanent cure, no certain prognosis, and infliction at a young age can result in numerous psychiatric disorders in patients (
10). In fact, studies conducted in this domain have shown that patients with MS experience higher levels of psychiatric disorders, such as anxiety and depression (
11); for example, the results of the meta - analysis by Marrie et al. (2015) revealed that the rates of prevalence of anxiety, bipolar disorders, depression, and psychosis were equal to 21.9%, 5.83%, 23.7%, and 4.3%, respectively (
12).
Among the problems affecting patients with MS is fatigue, which is also one of the most important factors influencing quality of life in these patients (
13). In this respect, fatigue refers to the absence of adequate physical and mental energy leading to disruptions in daily living activities (
14,
15). There are two main causes of fatigue, known as primary and secondary causes. The primary causes are associated with disease progression and due to damage to the central nervous system (
16). The secondary causes refer to problems, such as depression, poor nutrition, sleep disorders, pain, infection, drug complications, and type of MS (
17,
18). Fatigue in these patients, given that it is highly dependent on the person and its experience is different in individuals, is considered as a complicated and extremely incurable disorder. Due to the prevalence of this disorder, most people with MS complain about fatigue and its debilitating impacts on their daily life routines during outpatient examinations so that the given disorder can have an effect on fulfilling their jobs outside the house and accepting responsibilities for doing housework (
19).
Fatigue can be somewhat controlled with medications, such as amantadine, however, it seems logical to use non - pharmacological methods to lower fatigue due to complications caused by medication therapy (
8). These patients can certainly control fatigue, increase their abilities to perform daily activities, and develop adaptive behaviors provided that they are aware of non - pharmacological approaches that reduce fatigue. Access to health in chronic diseases is possible by making adjustments in various aspects of the patient’s life (
20). Among the non - pharmacological approaches that can be used to alleviate fatigue are nursing interventions, such as the use of Roy’s Adaptation Model (
8), progressive muscle relaxation (
21), home - based pulmonary rehabilitation (
22), self - management program (
23), and Pilates in resistance and combined forms (
24). Motivational interviewing is also one of the other non - pharmacological approaches employed to promote health status among patients with MS (
10,
25).
Motivational interviewing is a patient - centered approach that enhances intrinsic motivation among individuals to change their behaviors via the investigation and resolution of ambiguities, whose benefits in the domain of health have been widely accepted (
26). For the first time, motivational interviewing was introduced by Miller and Rollnick to treat addiction and, given its positive outcomes, it spread with a high speed in health promotion systems, especially chronic diseases, in which changes in behavior and giving motivation to patients are common challenges (
27). In fact, motivational interviewing is a promising intervention for positive health behavior change in the domains of medicine, mental health, and psychiatrics. In addition to flexibility and applicability of this type of behavioral intervention in various behavioral domains, it is also applicable to individuals and groups. It can cover clients from children to the elderly and is also used as an independent treatment or in combination with other therapies and in various forms, such as phone, in - person, and web - based interviewing (
28,
29).
This type of interview is comprised of four principles of Expression Empathy, Develop Discrepancy, Roll with Resistance, and Support Self - Efficacy, in order to establish relationships between patients and health workers and encourage patients to change their behaviors (
30,
31). One of the benefits of motivational interviewing is that it firstly raises an important and common problem in all therapies, i.e. resistance to change in a direct manner, and then fixes this problem. Furthermore, this type of interview is a flexible method and can be used as an independent approach combined with other therapies (
32).